{"id":"W1989987919","doi":"10.1007/s10637-006-5938-1","title":"Phase II trial of DNA methyltransferase 1 inhibition with the antisense oligonucleotide MG98 in patients with metastatic renal carcinoma: A National Cancer Institute of Canada Clinical Trials Group investigational new drug study","year":2006,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":131,"is_retracted":false,"has_abstract":false,"ca_institutions":"Pyrogenesis (Canada); Queen's University; London Health Sciences Centre; Hôpital Notre-Dame; Princess Margaret Cancer Centre; University Health Network; Queen Elizabeth II Health Sciences Centre","funders":"National Cancer Institute; Medical Research Council; University Health Network","keywords":"Clinical trial; Medicine; Renal cell carcinoma; Cancer; Phases of clinical research; Drug; Oncology; Cancer drugs; Internal medicine; Pharmacology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001999899,0.0002630522,0.0005093298,0.0001289162,0.000133433,0.0000197205,0.000156263,0.00007466273,0.00001683836],"category_scores_gemma":[0.0005543831,0.0001906013,0.0001049852,0.0004070583,0.0003683377,0.00003689914,0.00004157131,0.0001747504,2.110804e-7],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007713508,"about_ca_system_score_gemma":0.005775711,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.0730341,"about_ca_topic_score_gemma":0.1738885,"domain_scores_codex":[0.9961763,0.0006963005,0.001349266,0.0004469519,0.001117201,0.0002139974],"domain_scores_gemma":[0.9980666,0.0002891591,0.0007331775,0.0002203996,0.0004935536,0.0001970927],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.09238487,0.02213201,0.3971632,0.000235843,0.00298112,0.00004494314,0.003030738,0.115294,0.303438,0.01183384,0.04374901,0.007712444],"study_design_scores_gemma":[0.3365597,0.01022512,0.3880836,0.0002553957,0.0008332907,0.000003209007,0.0002722959,0.0006133196,0.2500041,0.008932951,0.003117298,0.001099651],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960721,0.0001502334,0.0005168872,0.001270731,0.0001721354,0.001396217,0.0003504071,0.000004653006,0.00006667056],"genre_scores_gemma":[0.9957299,0.00000786487,0.002185426,0.0002197665,0.0004721833,0.00006199135,0.001162894,0.00002451767,0.0001354311],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2441748,"threshold_uncertainty_score":0.9998606,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03687109437820722,"score_gpt":0.3202348674483818,"score_spread":0.2833637730701745,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}